In this report, we show that breast cancer patients whose tumors show high levels of cyclin E expression also have a higher prevalence of DNA repair gene (e.g., BRCA1/2) alterations compared to those patients without cyclin E overexpression. This evidence concerns the gene BRCA1 and breast carcinoma.